Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
When a company’s founder and CEO sells a chunk of stock, investors want to know what it means for future performance....
An executive’s $3.6 million share sale can spark questions for investors. This comprehensive guide explains what the ...
Zcash jumped about 40% in a single session, signaling a renewed push for privacy-focused assets as institutions eye h...
As ad-tech rotates from pandemic-driven momentum to more measured growth, The Trade Desk faces a pivotal moment. This...
Bitcoin rose toward the $64,000 mark after June CPI fell 0.4%, while core CPI held at 2.6%. The market roles reversed...
In April, nebius group stock popped as investors weighed cloud and AI catalysts. This piece breaks down the drivers, ...
A surge in viral public whale liquidations on Hyperliquid is turning whale activity into a real-time trading signal, ...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
As Bitcoin trades through late May 2026, Claude AI maps a bullish arc that could push BTC toward 200K by year-end. Th...
NVIDIA’s edge in AI infrastructure goes beyond silicon speed. The real reason Nvidia holds its monopoly is a tightly ...
A private Highgrove moment sparks big conversations about money, privacy, and planning. This article breaks down prac...